علاج Сarcinomatosis في إسرائيل — احصل على 3 عيادات مختارة خصيصاً لك

The primary treatment for peritoneal carcinomatosis in Israel is a combined protocol of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. This approach removes visible tumors before circulating heated chemotherapy within the abdomen. Specialists at JCI-accredited centers like Sourasky Medical Center and Sheba Medical Center perform these complex procedures.

• Standard protocol: Combines debulking surgery with heated chemo to target microscopic cancer cells.
• Advanced equipment: Surgeons utilize pressurized aerosol mist (PIPAC) for patients ineligible for major surgery.
• Expert volume: Dr. Almog Ben Yaacov at Sheba has performed over 200 procedures since 2018.
• Treatment duration: Procedures involve 60–90 minutes of internal chemotherapy circulation at 42°C.

Bookimed Expert Insight: While many search for the lowest cost, Israeli packages reveal a critical stay-length difference. Sheba Medical Center bundles a 14-day hotel stay into their $68,000 package. This supports the intensive 6–12 month rehabilitation period often required. Sourasky Medical Center reports a 90% oncology success rate. Choosing a center with high patient volumes and integrated recovery housing is vital for managing post-operative needs.

Patient Consensus: Patients emphasize that while this treatment can significantly extend life, recovery is a long journey. Many suggest preparing for significant pain and potential infections during several months of rehabilitation.

Less invasive options for advanced peritoneal carcinomatosis in Israel focus on drug delivery and targeted technology. Pressureized Intraperitoneal Aerosol Chemotherapy (PIPAC) delivers meds via laparoscopy. It uses lower doses with fewer side effects. Other options include immunotherapy and NanoKnife technology for precise tumor destruction.

• PIPAC procedure: This laparoscopic approach applies pressurized chemotherapy as a mist for deeper penetration.
• Reduced dosage: PIPAC requires only 10% to 20% of standard chemotherapy doses, improving tolerance.
• NanoKnife technology: Sheba Medical Center offers Irreversible Electroporation (IRE) to destroy tumors without heat.
• Immunotherapy: Israeli oncologists use advanced agents like Keytruda to stimulate immune response against cancer.
• Robotic resections: Surgeons like Dr. Yuri Goldes perform robotic-assisted procedures to minimize surgical trauma.

Bookimed Expert Insight: Israeli specialists often bridge the gap between palliative care and aggressive surgery by combining techniques. Dr. Almog Ben Yaacov at Sheba Medical Center has performed over 200 HIPEC procedures. His training includes NanoKnife and microwave ablation. This allows for a tiered approach. If a patient is ineligible for full cytoreduction, specialists may use these focal technologies instead of traditional open surgery.

Patient Consensus: Patients emphasize the importance of getting a Peritoneal Cancer Index (PCI) score quickly. They note that catching the disease when the score is under 10 often opens doors to these less invasive, life-extending protocols.

Sheba Medical Center and Sourasky Medical Center are the primary Israeli facilities specializing in cytoreductive surgery and HIPEC. These JCI-accredited institutions utilize multidisciplinary teams to treat abdominal carcinomatosis. Expertise is concentrated in Tel Aviv and Ramat Gan with surgeons trained at top international oncology centers.

• HIPEC specialists: Dr. Almog Ben Yaacov at Sheba has performed 200+ procedures since 2018.
• National referral: Sourasky Medical Center serves as a major national center for complex oncology.
• Advanced techniques: Facilities offer laparoscopic HIPEC, robotic resections, and NanoKnife for targeted tumor tissue destruction.
• Package inclusions: Standard packages often cover preoperative PET/CT, MRI, and up to 8 hospital nights.

Bookimed Expert Insight: While many select hospitals based on general reputation, the volume of procedures is a stronger indicator of safety for HIPEC. At Sheba Medical Center, oncology specialists manage over 2 million patients annually. This high-volume environment allows surgeons like Dr. Almog Ben Yaacov to maintain specialized skill sets in complex CRS+HIPEC protocols that smaller facilities may not match.

Patient Consensus: Patients note that Israeli oncology protocols are often more aggressive than those in other countries. They emphasize the importance of confirming a surgeon's individual case volume rather than just the hospital's general ranking.

International patients can receive a preliminary carcinomatosis treatment plan in Israel through telemedicine and digital record review. Specialists use high-resolution imaging and pathology reports to assess candidacy for procedures like HIPEC. While not a final contract, these plans help confirm diagnostic accuracy and estimate required medical travel budgets.

• Record review: Surgeons evaluate PET/CT scans and histopathology to determine surgical feasibility remotely.
• Digital consultations: Oncologists use telemedicine for initial assessments and to discuss systemic therapy options.
• Cost estimates: Facilities provide detailed price quotes based on the proposed surgical or chemotherapy protocols.
• Treatment candidacy: Experts like Dr. Almog Ben Yaacov review cases to confirm HIPEC eligibility before travel.

Bookimed Expert Insight: While preliminary plans are available, large centers like Sheba and Sourasky often emphasize that a physical examination is vital for staging. For instance, packages at Sheba Medical Center include specific on-site diagnostics like cancer markers and PET/CT to confirm the final surgical roadmap. This is because carcinomatosis requires a precise assessment of disease spread that even high-quality scans may not fully capture remotely.

Patient Consensus: Patients note that while video calls are helpful for initial direction, surgeons usually require a 3 to 5 day in-person visit for staging before performing HIPEC. They also suggest requesting a written summary after virtual consults to simplify insurance pre-approval and visa applications.

Follow-up therapies in Israel after HIPEC focus on clinical monitoring and systemic adjuvant care to prevent recurrence. Patients undergo routine PET-CT scans and blood tests for tumor markers. Dedicated teams at JCI-accredited centers provide specialized nutritional support and physical therapy during the standard 3-to-6 month recovery period.

• Clinical monitoring: Check-ups occur every 3 months during the first year for surveillance.
• Imaging protocols: Regular PET-CT or CT scans track potential microscopic disease every 3–4 months.
• Alternative therapies: PIPAC is available for patients ineligible for repeated hyperthermic chemotherapy procedures.
• Supportive care: Hospitalization typically lasts 8–12 days with integrated nutritional and physical rehabilitation.

Bookimed Expert Insight: While most packages focus on the surgery itself, top-tier Israeli centers like Sheba Medical Center often include up to 14 days of hotel stay for long-term monitoring. This ensures specialists like Dr. Almog Ben Yaacov, who has performed 200+ procedures, can personally oversee the critical initial recovery phase. Checking for included hotel stays can reduce logistical stress during early follow-up.

Patient Consensus: Patients emphasize the need for direct communication with the surgical team regarding post-op protocols. Many find that specialized dietary support is essential during the two weeks of intravenous nutrition often required after surgery.